Cargando…
CMR Tissue Characterization in Patients with HFmrEF
The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adv...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912482/ https://www.ncbi.nlm.nih.gov/pubmed/31694263 http://dx.doi.org/10.3390/jcm8111877 |
_version_ | 1783479466360569856 |
---|---|
author | Doeblin, Patrick Hashemi, Djawid Tanacli, Radu Lapinskas, Tomas Gebker, Rolf Stehning, Christian Motzkus, Laura Astrid Blum, Moritz Tahirovic, Elvis Dordevic, Aleksandar Kraft, Robin Zamani, Seyedeh Mahsa Pieske, Burkert Edelmann, Frank Düngen, Hans-Dirk Kelle, Sebastian |
author_facet | Doeblin, Patrick Hashemi, Djawid Tanacli, Radu Lapinskas, Tomas Gebker, Rolf Stehning, Christian Motzkus, Laura Astrid Blum, Moritz Tahirovic, Elvis Dordevic, Aleksandar Kraft, Robin Zamani, Seyedeh Mahsa Pieske, Burkert Edelmann, Frank Düngen, Hans-Dirk Kelle, Sebastian |
author_sort | Doeblin, Patrick |
collection | PubMed |
description | The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling. We, therefore, examined 17 patients with HFpEF, 18 with HFmrEF, 17 with HFrEF and 17 healthy, age-matched controls with cardiac MRI (Phillips 1.5 T). T1 and T2 relaxation time mapping was performed and the extracellular volume (ECV) was calculated. Global circumferential (GCS) and longitudinal strain (GLS) were derived from cine images. GLS (−15.7 ± 2.1) and GCS (−19.9 ± 4.1) were moderately reduced in HFmrEF, resembling systolic dysfunction. Native T1 relaxation times were elevated in HFmrEF (1027 ± 40 ms) and HFrEF (1033 ± 54 ms) compared to healthy controls (972 ± 31 ms) and HFpEF (985 ± 32 ms). T2 relaxation times were elevated in HFmrEF (55.4 ± 3.4 ms) and HFrEF (56.0 ± 6.0 ms) compared to healthy controls (50.6 ± 2.1 ms). Differences in ECV did not reach statistical significance. HFmrEF differs from healthy controls and shares similarities with HFrEF in cardiac MRI parameters of fibrosis and inflammation. |
format | Online Article Text |
id | pubmed-6912482 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69124822020-01-02 CMR Tissue Characterization in Patients with HFmrEF Doeblin, Patrick Hashemi, Djawid Tanacli, Radu Lapinskas, Tomas Gebker, Rolf Stehning, Christian Motzkus, Laura Astrid Blum, Moritz Tahirovic, Elvis Dordevic, Aleksandar Kraft, Robin Zamani, Seyedeh Mahsa Pieske, Burkert Edelmann, Frank Düngen, Hans-Dirk Kelle, Sebastian J Clin Med Article The characteristics and optimal management of heart failure with a moderately reduced ejection fraction (HFmrEF, LV-EF 40–50%) are still unclear. Advanced cardiac MRI offers information about function, fibrosis and inflammation of the myocardium, and might help to characterize HFmrEF in terms of adverse cardiac remodeling. We, therefore, examined 17 patients with HFpEF, 18 with HFmrEF, 17 with HFrEF and 17 healthy, age-matched controls with cardiac MRI (Phillips 1.5 T). T1 and T2 relaxation time mapping was performed and the extracellular volume (ECV) was calculated. Global circumferential (GCS) and longitudinal strain (GLS) were derived from cine images. GLS (−15.7 ± 2.1) and GCS (−19.9 ± 4.1) were moderately reduced in HFmrEF, resembling systolic dysfunction. Native T1 relaxation times were elevated in HFmrEF (1027 ± 40 ms) and HFrEF (1033 ± 54 ms) compared to healthy controls (972 ± 31 ms) and HFpEF (985 ± 32 ms). T2 relaxation times were elevated in HFmrEF (55.4 ± 3.4 ms) and HFrEF (56.0 ± 6.0 ms) compared to healthy controls (50.6 ± 2.1 ms). Differences in ECV did not reach statistical significance. HFmrEF differs from healthy controls and shares similarities with HFrEF in cardiac MRI parameters of fibrosis and inflammation. MDPI 2019-11-05 /pmc/articles/PMC6912482/ /pubmed/31694263 http://dx.doi.org/10.3390/jcm8111877 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Doeblin, Patrick Hashemi, Djawid Tanacli, Radu Lapinskas, Tomas Gebker, Rolf Stehning, Christian Motzkus, Laura Astrid Blum, Moritz Tahirovic, Elvis Dordevic, Aleksandar Kraft, Robin Zamani, Seyedeh Mahsa Pieske, Burkert Edelmann, Frank Düngen, Hans-Dirk Kelle, Sebastian CMR Tissue Characterization in Patients with HFmrEF |
title | CMR Tissue Characterization in Patients with HFmrEF |
title_full | CMR Tissue Characterization in Patients with HFmrEF |
title_fullStr | CMR Tissue Characterization in Patients with HFmrEF |
title_full_unstemmed | CMR Tissue Characterization in Patients with HFmrEF |
title_short | CMR Tissue Characterization in Patients with HFmrEF |
title_sort | cmr tissue characterization in patients with hfmref |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912482/ https://www.ncbi.nlm.nih.gov/pubmed/31694263 http://dx.doi.org/10.3390/jcm8111877 |
work_keys_str_mv | AT doeblinpatrick cmrtissuecharacterizationinpatientswithhfmref AT hashemidjawid cmrtissuecharacterizationinpatientswithhfmref AT tanacliradu cmrtissuecharacterizationinpatientswithhfmref AT lapinskastomas cmrtissuecharacterizationinpatientswithhfmref AT gebkerrolf cmrtissuecharacterizationinpatientswithhfmref AT stehningchristian cmrtissuecharacterizationinpatientswithhfmref AT motzkuslauraastrid cmrtissuecharacterizationinpatientswithhfmref AT blummoritz cmrtissuecharacterizationinpatientswithhfmref AT tahirovicelvis cmrtissuecharacterizationinpatientswithhfmref AT dordevicaleksandar cmrtissuecharacterizationinpatientswithhfmref AT kraftrobin cmrtissuecharacterizationinpatientswithhfmref AT zamaniseyedehmahsa cmrtissuecharacterizationinpatientswithhfmref AT pieskeburkert cmrtissuecharacterizationinpatientswithhfmref AT edelmannfrank cmrtissuecharacterizationinpatientswithhfmref AT dungenhansdirk cmrtissuecharacterizationinpatientswithhfmref AT kellesebastian cmrtissuecharacterizationinpatientswithhfmref |